Evaluation of the new blood-pool CT contrast agent VivoVist in mouse models. [PDF]
Livingston EW +5 more
europepmc +1 more source
Diffuse MRI Edema Predicts Relapse in Cerebral Amyloid Angiopathy–Related Inflammation
ABSTRACT Objective To identify MRI predictors of relapse and quantify relapse and mortality risk in cerebral amyloid angiopathy–related inflammation (CAA‐RI). A secondary objective was to assess the association between mycophenolate mofetil use and relapse risk. Methods We performed a retrospective cohort study of 36 patients with CAA‐RI treated at the
G. Abbas Kharal +10 more
wiley +1 more source
Impact of Contrast Agent Viscosity and Fallopian Tube Inner Diameter on Tubal Visualization in MR Hysterosalpingography: A Phantom Study [PDF]
Ding J +5 more
europepmc +1 more source
Efficient estimation of gadolinium-based contrast agent concentration using transient-state keyhole MR-STAT. [PDF]
Xu F +7 more
europepmc +1 more source
Safety of a Tailored Gadolinium-Based Contrast Agent Protocol Considering Excretion Pathways in Patients with Renal Impairment. [PDF]
Kim JW, Lee CH, Ko GJ, Suh SI.
europepmc +1 more source
Echocardiographic Evaluation of the Right Ventricular Thickness, Myocardial Visualization, and Fractional Area Change: The Impact of Contrast Agent and Transducer Selection. [PDF]
Park Y +5 more
europepmc +1 more source
Gadolinium Intermediate Elimination and Persistent Symptoms After Magnetic Resonance Imaging Contrast Agent Exposure. [PDF]
Wagner B +15 more
europepmc +1 more source
Related searches:
Contrast agents in diagnostic ultrasound
Ultrasound in Medicine and Biology, 1989We review the field of contrast agents in diagnostic ultrasound. The progress in the development of various classes of contrast agents such as free and encapsulated gas bubbles, colloidal suspensions, emulsions, and aqueous solutions is described. The mechanisms for production of backscatter contrast, as well as attenuation contrast and speed of sound ...
Kevin J Parker, Jonathan Ophir, J Ophir
exaly +4 more sources
Pharmacologic development and clinical use of nonionic low osmolality contrast agents have lowered incidences of contrast reactions. Exclusive use of these agents may be limited owing to their high costs. Ionic high osmolality agents still provide reliable means of positive contrast enhancement, and minimal problems with reactions have been experienced
openaire +2 more sources

